Affymax, Inc. (AFFY)

OTCMKTS · Delayed Price · Currency is USD
0.0026
+0.0015 (136.36%)
At close: Dec 5, 2025
225.00%
Market Cap193.67K
Revenue (ttm)42.00K
Net Income (ttm)3.07M
Shares Out74.49M
EPS (ttm)0.08
PE Ratio0.03
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume151,045
Average Volume37,655
Open0.0024
Previous Close0.0011
Day's Range0.0008 - 0.0026
52-Week Range0.0001 - 0.0030
Beta7.80
RSI59.59
Earnings Daten/a

About Affymax

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol AFFY
Full Company Profile

Financial Performance

In 2013, Affymax's revenue was $1.37 million, a decrease of -98.55% compared to the previous year's $94.37 million. Losses were -$14.42 million, -84.56% less than in 2012.

Financial Statements

News

There is no news available yet.